
• The Effects of NN1731 and High-Dose rFVIIa in Severe Hemophiliacs Poorly Responsive to in In Vivo Dosing of rFVIIa 90 mcg/kg (enrolling fall of 2009)
• Correlation between Vitamin D status and Bone Mineral Density in Patients with Hemophilia A (enrolling fall of 2009)
• CHAVI 014 Investigation of Gene Variants Associated with Resistance and Susceptibility to HIV (enrolling summer of 2009)
• Phase I Trial of Pegylated Recombinant Factor IX (enrolling summer of 2009)
• Universal Data and Serum Collection Study,
sponsored by the Centers for Disease Control (currently
enrolling)
• Universal Data and Serum Collection Study Inhibitor Pilot Addendum, sponsored by the Centers for Disease Control (currently enrolling)
|